中期至晚期不可切除的肝细胞癌的治疗正在转向一个多学科的策略,包括多种治疗方式,如有需要
Ken Sato1,2
1Department of Healthcare Informatics, Takasaki University of Health and Welfare, Takasaki 370-0033, Japan.
World journal of gastroenterology
|March 17, 2025
概括
贝瓦西祖马布和伦瓦提尼布在结合干预疗法和免疫疗法治疗不可切除的肝细胞癌时表现出类似的疗效和安全性. 这一发现支持肝癌治疗中的组合疗法选择.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学瘤学 医学瘤学
- 胃肠病学 胃肠病学
背景情况:
- 肝细胞癌 (HCC) 是一个重要的全球健康问题.
- 中级至高级不可切除的HCC需要有效的组合疗法.
- 与干预疗法和免疫疗法 (IMT) 结合的分子向药物是新兴的治疗策略.
研究的目的:
- 为了比较bevacizumab与lenvatinib的疗效和不良反应.
- 评估这些药物与IMT结合用于不可切除的HCC.
- 为 HCC 治疗中个性化医疗方法提供证据.
主要方法:
- 一项对比性研究评估了贝瓦西祖马布和伦瓦提尼布.
- 组合疗法包括干预疗法和免疫疗法.
- 评估治疗疗效和不良事件概况.
主要成果:
- 在贝瓦西祖马布和伦瓦提尼布之间没有观察到有效性的显著差异.
- 两种药物之间没有发现副作用的显著差异.
- 分子向治疗与IMT的结合是可行的,需要进一步研究.
结论:
- 贝瓦西祖马布和伦瓦提尼布在HCC的联合治疗中表现出类似的结果.
- 治疗策略可能会受到区域保险限制的影响.
- 对包括先进放射疗法在内的多模组合疗法的进一步研究对于推进个性化HCC治疗至关重要.
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


